A product-linked NFC identity designed for one-tap verification.
Dual incretin receptor research
Tirzepatide
Single-molecule dual GIP and GLP-1 receptor agonist documented across five presentations.
Explore presentation-specific analytical records covering identity, purity, measured content, lot traceability and downloadable Certificates of Analysis.
Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.
Product authentication
Authenticity, built into every product.
Powered by NFC. Secured by blockchain. Verified instantly.
Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.
A blockchain-secured record supporting authenticity and traceability.
Presentation-specific COAs document identity, purity, measured content and lot information.
Product information
Dual-incretin receptor research, documented by batch.
Tirzepatide is a 39-amino-acid peptide engineered to engage both GIP and GLP-1 receptor pathways. This research-only Royal Pharma page connects five presentations to their individual identity, purity and content records.
Research class
Dual GIP / GLP-1 receptor agonistDocumentation status
Research reference compoundReference CAS
2023788-19-2Physical form
White lyophilised powderResearch profile
One sequence. Two incretin receptors.
Receptor-pharmacology research examines how combined GIP and GLP-1 activity differs from single-pathway agonism. The supplied certificates concern only the submitted samples and do not provide clinical-use instructions.
One arm of the molecule's dual incretin receptor profile.
The second receptor arm included in the dual-agonist design.
The 39-residue sequence includes a lipid-associated extension strategy.
Quality documentation
Certificate of Analysis
Choose a presentation to display the exact analytical record
supplied for that sample.
The supplied certificates state that the tested materials are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.